Lab Draw Associated Blood Loss in Euvolemic Hemodynamically Stable Surgical ICU Patients

Overview

About this study

The purpose of this study is to determine the average volume of blood drawn in a 24 hour period in a hemodynamically stable, euvolemic Trauma/Surgical ICU patient and compare the actual volumes of blood loss with routine phlebotomy to expected losses. 

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • ≥ 18 years of age
  • Hemodynamically stable, euvolemic patients defined as systolic blood pressure ≥90 mmHg and not requiring any of the following
    • Increasing doses of vasopressor support
    • Patients receiving blood products as part of the massive transfusion protocol
    • Blood administration outside of the massive transfusion protocol ≥3 units in 1 hour
    • Crystalloid or colloid fluid administration at a rate ≥2L in previous 3 hours
  • Anticipated length of ICU stay of ≥24 hours at the time of enrollment

Exclusion Criteria: 

  • Age <18
  • Pregnant patients
  • Prisoners
  • Patients going to the operating room or for any other invasive procedure during the 24 hour study period

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Mark Sawyer, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions